Drug Utilization Study Evaluating Additional Risk Minimisation Measures for Upadacitinib in the Treatment of Ulcerative Colitis in Europe

ENCePP Code of conduct

Yes

Data sources

• Data source(s):
  Danish registries (access/analysis)

  Sweden National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  - SWIBREG, Sweden ; - SMINET, Sweden; - Swedish National Registers; - ENEIDA, Spain
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Other
• Data sources (types), other:
  Pharmacy dispensing records, quality register, medical chart abstraction

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.